BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 24860144)

  • 1. Metabolism and mis-metabolism of the neuropathological signature protein TDP-43.
    Huang CC; Bose JK; Majumder P; Lee KH; Huang JT; Huang JK; Shen CK
    J Cell Sci; 2014 Jul; 127(Pt 14):3024-38. PubMed ID: 24860144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTK2/FAK regulates UPS impairment via SQSTM1/p62 phosphorylation in TARDBP/TDP-43 proteinopathies.
    Lee S; Jeon YM; Cha SJ; Kim S; Kwon Y; Jo M; Jang YN; Lee S; Kim J; Kim SR; Lee KJ; Lee SB; Kim K; Kim HJ
    Autophagy; 2020 Aug; 16(8):1396-1412. PubMed ID: 31690171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A new dementia group caused by TDP-43 abnormality].
    Arai T; Hosokawa M; Hasegawa M; Akiyama H; Asada T
    Seishin Shinkeigaku Zasshi; 2011; 113(6):574-83. PubMed ID: 21815469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TDP-43 proteinopathies: neurodegenerative protein misfolding diseases without amyloidosis.
    Kwong LK; Uryu K; Trojanowski JQ; Lee VM
    Neurosignals; 2008; 16(1):41-51. PubMed ID: 18097159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential roles of the ubiquitin proteasome system and autophagy in the clearance of soluble and aggregated TDP-43 species.
    Scotter EL; Vance C; Nishimura AL; Lee YB; Chen HJ; Urwin H; Sardone V; Mitchell JC; Rogelj B; Rubinsztein DC; Shaw CE
    J Cell Sci; 2014 Mar; 127(Pt 6):1263-78. PubMed ID: 24424030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic effect of berberine on TDP-43-related pathogenesis in FTLD and ALS.
    Chang CF; Lee YC; Lee KH; Lin HC; Chen CL; Shen CJ; Huang CC
    J Biomed Sci; 2016 Oct; 23(1):72. PubMed ID: 27769241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The molecular mechanisms of intracellular TDP-43 aggregates].
    Nonaka T; Arai T; Hasegawa M
    Brain Nerve; 2009 Nov; 61(11):1292-300. PubMed ID: 19938686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative assessment of the degradation of aggregated TDP-43 mediated by the ubiquitin proteasome system and macroautophagy.
    Cascella R; Fani G; Capitini C; Rusmini P; Poletti A; Cecchi C; Chiti F
    FASEB J; 2017 Dec; 31(12):5609-5624. PubMed ID: 28842427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neuropathology of TDP-43 proteinopathy].
    Akiyama H; Hasegawa M
    Brain Nerve; 2013 Dec; 65(12):1477-89. PubMed ID: 24323933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review: transactive response DNA-binding protein 43 (TDP-43): mechanisms of neurodegeneration.
    Gendron TF; Josephs KA; Petrucelli L
    Neuropathol Appl Neurobiol; 2010 Apr; 36(2):97-112. PubMed ID: 20202122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial Failure of Proteostasis Systems Counteracting TDP-43 Aggregates in Neurodegenerative Diseases.
    Cascella R; Fani G; Bigi A; Chiti F; Cecchi C
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31357627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel Drosophila model of TDP-43 proteinopathies: N-terminal sequences combined with the Q/N domain induce protein functional loss and locomotion defects.
    Langellotti S; Romano V; Romano G; Klima R; Feiguin F; Cragnaz L; Romano M; Baralle FE
    Dis Model Mech; 2016 Jun; 9(6):659-69. PubMed ID: 27101846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TDP-43 functions and pathogenic mechanisms implicated in TDP-43 proteinopathies.
    Cohen TJ; Lee VM; Trojanowski JQ
    Trends Mol Med; 2011 Nov; 17(11):659-67. PubMed ID: 21783422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TAR DNA-binding protein 43 in neurodegenerative disease.
    Chen-Plotkin AS; Lee VM; Trojanowski JQ
    Nat Rev Neurol; 2010 Apr; 6(4):211-20. PubMed ID: 20234357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chaperone Mediated Autophagy Degrades TDP-43 Protein and Is Affected by TDP-43 Aggregation.
    Ormeño F; Hormazabal J; Moreno J; Riquelme F; Rios J; Criollo A; Albornoz A; Alfaro IE; Budini M
    Front Mol Neurosci; 2020; 13():19. PubMed ID: 32132902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PABPN1 suppresses TDP-43 toxicity in ALS disease models.
    Chou CC; Alexeeva OM; Yamada S; Pribadi A; Zhang Y; Mo B; Williams KR; Zarnescu DC; Rossoll W
    Hum Mol Genet; 2015 Sep; 24(18):5154-73. PubMed ID: 26130692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Praja1 RING-finger E3 ubiquitin ligase suppresses neuronal cytoplasmic TDP-43 aggregate formation.
    Watabe K; Kato Y; Sakuma M; Murata M; Niida-Kawaguchi M; Takemura T; Hanagata N; Tada M; Kakita A; Shibata N
    Neuropathology; 2020 Dec; 40(6):570-586. PubMed ID: 32686212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TDP-43: a DNA and RNA binding protein with roles in neurodegenerative diseases.
    Warraich ST; Yang S; Nicholson GA; Blair IP
    Int J Biochem Cell Biol; 2010 Oct; 42(10):1606-9. PubMed ID: 20601083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Both cytoplasmic and nuclear accumulations of the protein are neurotoxic in Drosophila models of TDP-43 proteinopathies.
    Miguel L; Frébourg T; Campion D; Lecourtois M
    Neurobiol Dis; 2011 Feb; 41(2):398-406. PubMed ID: 20951205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers for diseases with TDP-43 pathology.
    Steinacker P; Barschke P; Otto M
    Mol Cell Neurosci; 2019 Jun; 97():43-59. PubMed ID: 30399416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.